Real-life study of safety of thiopurine-allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment-Reference-Cited by-同舟云学术

Real-life study of safety of thiopurine-allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment

Published:2019-07-30 Issue:4 Volume:50 Page:407-415
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Kreijne Joany E.¹^ORCID,de Veer Rozanne C.¹^ORCID,de Boer Nanne K.²,Dijkstra Gerard³,West Rachel⁴,Moorsel Sofia A. W.⁵^ORCID,de Jong Dirk J.⁶,van der Woude C. Janneke¹,de Vries Annemarie C.¹,

Affiliation:

1. Department of Gastroenterology and Hepatology; Erasmus MC University Medical Center; Rotterdam The Netherlands

2. Department of Gastroenterology and Hepatology; Amsterdam UMC, Vrije Universiteit Amsterdam, AG&M Research Institute; Amsterdam The Netherlands

3. Department of Gastroenterology and Hepatology; University Medical Center Groningen and University of Groningen; Groningen The Netherlands

4. Department of Gastroenterology and Hepatology; Sint Franciscus Gasthuis & Vlietland; Rotterdam The Netherlands

5. Department of Pharmacology; Zuyderland Medical Center; Heerlen-Sittard-Geleen The Netherlands

6. Department of Gastroenterology and Hepatology; Radboud University Medical Center; Nijmegen The Netherlands

Funder

Erasmus Medisch Centrum

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15402/fullpdf

Reference34 articles.

1. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease;Dubinsky;Gastroenterology,2000

2. Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism;Schwab;Pharmacogenetics,2002

3. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review;Fraser;Gut,2002

4. 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity;Present;Ann Intern Med,1989

5. Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience;Connell;Gut,1993

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multicentre study and systematic review: Allopurinol exposure during pregnancy;Alimentary Pharmacology & Therapeutics;2024-07-10

2. Exploring the role of oxidative stress and the effect of N‐acetylcysteine in thiopurine‐induced liver injury in inflammatory bowel disease: A randomized crossover pilot study;Basic & Clinical Pharmacology & Toxicology;2024-01-29

3. The Effectiveness and Safety of First-Line Thioguanine in Thiopurine-Naïve Inflammatory Bowel Disease Patients;Inflammatory Bowel Diseases;2023-09-02

4. Predictive Algorithm for Thiopurine-Induced Hepatotoxicity in Inflammatory Bowel Disease Patients;Therapeutic Drug Monitoring;2022-12

5. Prediction of thiopurine failure in pediatric Crohn’s disease: pediatric IBD Porto group of ESPGHAN;Pediatric Research;2022-08-25